Amidebio, LLC
Louisville, CO Doing business as Amidebio LLC Amidebio LLC
- UEI
- UN9KNR7J6J77
- CAGE
- 5NBN2
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 331 S 104th St, Louisville, CO 80027, USA
- Website
- amidebio.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Dual agonist insulins for treating diabetics with impaired awareness ofhypoglycemia (IAH) - summary/abstract diabetes is… | National Institute of Diabetes and Digestive and Kidney Diseases | $1,929,408 | |
| Novel glucose responsive insulin for improved treatment of diabetes - summary/abstract. Diabetes is rapidly becoming a… | National Institute of Diabetes and Digestive and Kidney Diseases | $783,955 | |
| Stable glucagon for treatment of hyperinsulinism | National Institute of Diabetes and Digestive and Kidney Diseases | $6,825,522 | |
| Stable glucagon for treatment of hyperinsulinism | National Institute of Diabetes and Digestive and Kidney Diseases | $338,388 |
Quick answers
What is Amidebio, LLC's UEI?
Amidebio, LLC's Unique Entity ID (UEI) in SAM.gov is UN9KNR7J6J77.
What is Amidebio, LLC's CAGE code?
Amidebio, LLC's CAGE code is 5NBN2.
What is Amidebio, LLC's primary NAICS code?
Amidebio, LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Amidebio, LLC located?
Amidebio, LLC's physical address in SAM.gov is 331 S 104th St, Louisville, CO 80027, USA.
Is Amidebio, LLC registered in SAM.gov?
Yes. Amidebio, LLC's SAM.gov registration is active through January 5, 2027.
What is Amidebio, LLC's most recent federal award?
Amidebio, LLC's most recent federal grant award is Dual agonist insulins for treating diabetics with impaired awareness ofhypoglycemia (IAH) - summary/abstract diabetes is… (R44DK141357), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 1, 2024.
On GovTribe
See Amidebio, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors